These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14963648)

  • 1. Silent myocardial infarction and its prognosis in a community-based cohort of Type 2 diabetic patients: the Fremantle Diabetes Study.
    Davis TME; Fortun P; Mulder J; Davis WA; Bruce DG
    Diabetologia; 2004 Mar; 47(3):395-399. PubMed ID: 14963648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cardiac magnetic resonance imaging study of electrocardiographic Q waves in type 2 diabetes: the Fremantle Diabetes Study.
    Kondola S; Davis WA; Dembo LG; Davis TM
    Diabetes Res Clin Pract; 2008 Oct; 82(1):87-92. PubMed ID: 18678430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Silent myocardial ischemia during Holter monitoring in patients with diabetes mellitus].
    Marín Huerta E; Rayo I; Lara JI; Cuéllar L; de la Calle H; Romero J; del Río A; Muela A; Aza V
    Rev Esp Cardiol; 1989 Oct; 42(8):519-29. PubMed ID: 2602608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics, left and right ventricular ejection fraction, and long-term prognosis in patients with non-insulin-dependent diabetes surviving an acute myocardial infarction.
    Melchior T; Gadsbøll N; Hildebrandt P; Køber L; Torp-Pedersen C
    Diabet Med; 1996 May; 13(5):450-6. PubMed ID: 8737027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of coronary heart disease in Type 2 diabetic patients in Italy: the DAI study.
    DAI Study Group
    Diabet Med; 2004 Jul; 21(7):738-45. PubMed ID: 15209767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One quarter of total myocardial infarctions are silent manifestation in patients with type 2 diabetes mellitus.
    Soejima H; Ogawa H; Morimoto T; Okada S; Sakuma M; Nakayama M; Masuda I; Doi N; Uemura S; Jinnouchi H; Sugiyama S; Waki M; Saito Y;
    J Cardiol; 2019 Jan; 73(1):33-37. PubMed ID: 30487058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location.
    Avogaro A; Giorda C; Maggini M; Mannucci E; Raschetti R; Lombardo F; Spila-Alegiani S; Turco S; Velussi M; Ferrannini E;
    Diabetes Care; 2007 May; 30(5):1241-7. PubMed ID: 17290034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of silent myocardial infarction in newly diagnosed type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 79.
    Davis TM; Coleman RL; Holman RR;
    Circulation; 2013 Mar; 127(9):980-7. PubMed ID: 23362315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrocardiography-defined silent CHD and risk of cardiovascular events among diabetic patients in a Middle Eastern population.
    Hadaegh F; Hatami M; Mohebi R; Hasheminia M; Bozorgmanesh M; Sheikholeslami F; Azizi F
    Eur J Prev Cardiol; 2012 Dec; 19(6):1227-33. PubMed ID: 22013153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
    Armstrong PW; Fu Y; Westerhout CM; Hudson MP; Mahaffey KW; White HD; Todaro TG; Adams PX; Aylward PE; Granger CB
    J Am Coll Cardiol; 2009 Apr; 53(17):1503-9. PubMed ID: 19389560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silent coronary heart disease in patients with type 2 diabetes: application of a screening approach in a follow-up study.
    Vigili de Kreutzenberg S; Solini A; Vitolo E; Boi A; Bacci S; Cocozza S; Nappo R; Rivellese A; Avogaro A; Baroni MG
    J Diabetes Complications; 2017 Jun; 31(6):952-957. PubMed ID: 28416121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does silent myocardial infarction add prognostic value in ST-elevation myocardial infarction patients without a history of prior myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial.
    Toma M; Fu Y; Ezekowitz JA; McAlister FA; Westerhout CM; Granger CB; Armstrong PW
    Am Heart J; 2010 Oct; 160(4):671-7. PubMed ID: 20934561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary atherosclerosis in Type II diabetes: angiographic findings and clinical outcome.
    Natali A; Vichi S; Landi P; Severi S; L'Abbate A; Ferrannini E
    Diabetologia; 2000 May; 43(5):632-41. PubMed ID: 10855538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of perioperative Q-wave myocardial infarction: the Emory Angioplasty versus Surgery Trial.
    Hodakowski GT; Craver JM; Jones EL; King SB; Guyton RA
    J Thorac Cardiovasc Surg; 1996 Dec; 112(6):1447-53; discussion 1453-4. PubMed ID: 8975835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xuezhikang, an extract of cholestin, reduces cardiovascular events in type 2 diabetes patients with coronary heart disease: subgroup analysis of patients with type 2 diabetes from China coronary secondary prevention study (CCSPS).
    Zhao SP; Lu ZL; Du BM; Chen Z; Wu YF; Yu XH; Zhao YC; Liu L; Ye HJ; Wu ZH;
    J Cardiovasc Pharmacol; 2007 Feb; 49(2):81-4. PubMed ID: 17312447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of previous coronary-artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction. Bypass Angioplasty Revascularization Investigation Investigators.
    Detre KM; Lombardero MS; Brooks MM; Hardison RM; Holubkov R; Sopko G; Frye RL; Chaitman BR
    N Engl J Med; 2000 Apr; 342(14):989-97. PubMed ID: 10749960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent trends in acute coronary heart disease--mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators.
    McGovern PG; Pankow JS; Shahar E; Doliszny KM; Folsom AR; Blackburn H; Luepker RV
    N Engl J Med; 1996 Apr; 334(14):884-90. PubMed ID: 8596571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Factors influencing cardiac complications in patients with type-2 diabetes mellitus and silent myocardial ischaemia: five-year follow-up].
    Mamcarz A; Chmielewski M; Braksator W; Syska-Sumńska J; Janiszewski M; Król J; Kuch M; Kuch J; Dłuiniewski M
    Pol Arch Med Wewn; 2004 Dec; 112(6):1433-43. PubMed ID: 15962608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of Q waves on presentation and ST resolution in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Kumar S; Hsieh C; Sivagangabalan G; Chan H; Ryding AD; Narayan A; Ong AT; Sadick N; Kovoor P
    Am J Cardiol; 2009 Sep; 104(6):780-5. PubMed ID: 19733711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of major coronary events by coronary risk profile and silent myocardial ischaemia: prospective follow-up study of primary prevention in 72 diabetic patients.
    Torremocha F; Hadjadj S; Carrié F; Rosenberg T; Herpin D; Maréchaud R
    Diabetes Metab; 2001 Feb; 27(1):49-57. PubMed ID: 11240446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.